{
  "text": "People with a BRCA-2 mutation are smarter than the general population.",
  "status": "processed",
  "additional_info": "{\"supportingPapers\": [], \"nonRelevantPapers\": [{\"title\": \"Addressing Sexual Dysfunction After Risk-Reducing Salpingo-Oophorectomy: Effects of a Brief, Psychosexual Intervention\", \"authors\": [{\"name\": \"Sharon L. Bober\", \"authorId\": \"A5035514847\"}, {\"name\": \"Christopher J. Recklitis\", \"authorId\": \"A5082497284\"}, {\"name\": \"Jennifer Bakan\", \"authorId\": \"A5012041102\"}, {\"name\": \"Judy E. Garber\", \"authorId\": \"A5005206482\"}, {\"name\": \"Andrea Farkas Patenaude\", \"authorId\": \"A5039854332\"}], \"link\": \"https://europepmc.org/articles/pmc4304978?pdf=render\", \"explanation\": \"The paper focuses on addressing sexual dysfunction and psychological distress in women with BRCA1/2 mutations who have undergone risk-reducing salpingo-oophorectomy (RRSO). It does not discuss or provide any data related to cognitive abilities or intelligence of individuals with BRCA-2 mutations. Therefore, it is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"CEL I Enzymatic Mutation Detection Assay\", \"authors\": [{\"name\": \"Joanne Kulinski\", \"authorId\": \"A5003757668\"}, {\"name\": \"David Besack\", \"authorId\": \"A5065247740\"}, {\"name\": \"Catherine A. Oleykowski\", \"authorId\": \"A5029826903\"}, {\"name\": \"Andrew K. Godwin\", \"authorId\": \"A5033625395\"}, {\"name\": \"Anthony T. Yeung\", \"authorId\": \"A5069206173\"}], \"link\": \"https://www.future-science.com/doi/pdf/10.2144/00291bm07\", \"explanation\": \"The paper content provided is focused on mutation detection technologies and methods, particularly related to BRCA1 and BRCA2 mutations in the context of cancer research. It does not address cognitive abilities or intelligence in individuals with BRCA-2 mutations. Therefore, it is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"BRCA1 Testing in Families With Hereditary Breast-Ovarian Cancer\", \"authors\": [{\"name\": \"Caryn Lerman\", \"authorId\": \"A5061725200\"}], \"link\": \"https://doi.org/10.1001/jama.1996.03530480027036\", \"explanation\": \"The paper focuses on the utilization of BRCA1 gene testing and its psychological and health-related outcomes. It does not address the BRCA-2 mutation or any cognitive or intelligence-related outcomes associated with BRCA-2 mutation carriers. Therefore, it is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"Molecular profiling for precision cancer therapies\", \"authors\": [{\"name\": \"Eoghan Ruadh Malone\", \"authorId\": \"A5021603375\"}, {\"name\": \"Marc Oliva\", \"authorId\": \"A5054682698\"}, {\"name\": \"Peter Sabatini\", \"authorId\": \"A5065782582\"}, {\"name\": \"Tracy Stockley\", \"authorId\": \"A5049924678\"}, {\"name\": \"Lillian L. Siu\", \"authorId\": \"A5000204204\"}], \"link\": \"https://genomemedicine.biomedcentral.com/track/pdf/10.1186/s13073-019-0703-1\", \"explanation\": \"The paper focuses on molecular profiling for precision cancer therapies and does not address cognitive abilities or intelligence in individuals with BRCA-2 mutations. It discusses genomic variants in the context of cancer treatment and precision medicine, which is unrelated to the claim about intelligence.\"}, {\"title\": \"Awareness and current knowledge of breast cancer\", \"authors\": [{\"name\": \"Muhammad Akram\", \"authorId\": \"A5089231002\"}, {\"name\": \"Mehwish Iqbal\", \"authorId\": \"A5009925902\"}, {\"name\": \"Muhammad Daniyal\", \"authorId\": \"A5027767149\"}, {\"name\": \"Asmat Ullah Khan\", \"authorId\": \"A5049279306\"}], \"link\": \"https://biolres.biomedcentral.com/track/pdf/10.1186/s40659-017-0140-9\", \"explanation\": \"The paper is a comprehensive review of breast cancer, covering topics such as risk factors, diagnosis, treatment, and epidemiology. It does not address cognitive abilities or intelligence in individuals with BRCA-2 mutations or any other genetic mutations. The claim about BRCA-2 mutation carriers being smarter than the general population is not discussed or supported by any content in this paper.\"}, {\"title\": \"Estrogens, Neuroinflammation, and Neurodegeneration\", \"authors\": [{\"name\": \"Alessandro Villa\", \"authorId\": \"A5016070892\"}, {\"name\": \"Elisabetta Vegeto\", \"authorId\": \"A5009671696\"}, {\"name\": \"Angelo Poletti\", \"authorId\": \"A5059962048\"}, {\"name\": \"Adriana Maggi\", \"authorId\": \"A5055666393\"}], \"link\": \"https://academic.oup.com/edrv/article-pdf/37/4/372/10492530/edrv0372.pdf\", \"explanation\": \"The paper focuses on the role of estrogens, neuroinflammation, and neurodegeneration, particularly in relation to microglia and various neurological disorders. It does not address cognitive abilities or intelligence in individuals with BRCA-2 mutations, nor does it compare the intelligence of such individuals to the general population. Therefore, the content is not relevant to the claim about BRCA-2 mutations and intelligence.\"}, {\"title\": \"Agents in bioinformatics, computational and systems biology\", \"authors\": [{\"name\": \"Emanuela Merelli\", \"authorId\": \"A5018586673\"}, {\"name\": \"Giuliano Armano\", \"authorId\": \"A5010844048\"}, {\"name\": \"Nicola Cannata\", \"authorId\": \"A5085201145\"}, {\"name\": \"Flavio Corradini\", \"authorId\": \"A5078426900\"}, {\"name\": \"Mark d\\u2019Inverno\", \"authorId\": \"A5003787881\"}, {\"name\": \"Andreas Doms\", \"authorId\": \"A5062561147\"}, {\"name\": \"Phillip Lord\", \"authorId\": \"A5059579347\"}, {\"name\": \"Andrew C.R. Martin\", \"authorId\": \"A5065605747\"}, {\"name\": \"Luciano Milanesi\", \"authorId\": \"A5088629765\"}, {\"name\": \"Steffen M\\u00f6ller\", \"authorId\": \"A5089261582\"}, {\"name\": \"Michael Schroeder\", \"authorId\": \"A5016411406\"}, {\"name\": \"G. Flucke\", \"authorId\": \"A5069481846\"}], \"link\": \"https://academic.oup.com/bib/article-pdf/8/1/45/734808/bbl014.pdf\", \"explanation\": \"The paper discusses the use of agent technologies and multi-agent systems in bioinformatics, focusing on computational frameworks and systems modeling. It does not address genetic mutations, intelligence, or any specific information about the BRCA-2 mutation or its effects on cognitive abilities. Therefore, it is not relevant to the claim about the intelligence of people with a BRCA-2 mutation.\"}, {\"title\": \"Problems, challenges and promises: perspectives on precision medicine\", \"authors\": [{\"name\": \"David J. Duffy\", \"authorId\": \"A5043130109\"}], \"link\": \"https://academic.oup.com/bib/article-pdf/17/3/494/6687486/bbv060.pdf\", \"explanation\": \"The paper focuses on precision medicine, its challenges, and its implementation in healthcare. It does not discuss cognitive abilities or intelligence in relation to BRCA-2 mutations or any genetic mutations. Therefore, it is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"Genetic/Familial High-Risk Assessment: Breast and Ovarian\", \"authors\": [{\"name\": \"Mary B. Daly\", \"authorId\": \"A5107933751\"}, {\"name\": \"Jennifer E. Axilbund\", \"authorId\": \"A5082031575\"}, {\"name\": \"Saundra S. Buys\", \"authorId\": \"A5075169712\"}, {\"name\": \"James M. Ford\", \"authorId\": \"A5000788791\"}, {\"name\": \"Carolyn Farrell\", \"authorId\": \"A5074799586\"}, {\"name\": \"Susan J. Friedman\", \"authorId\": \"A5109631766\"}, {\"name\": \"Judy E. Garber\", \"authorId\": \"A5005206482\"}, {\"name\": \"Salil Goorha\", \"authorId\": \"A5113060725\"}, {\"name\": \"Stephen B. Gruber\", \"authorId\": \"A5104754142\"}, {\"name\": \"Heather Hampel\", \"authorId\": \"A5012798070\"}, {\"name\": \"Virginia Kaklamani\", \"authorId\": \"A5047918797\"}, {\"name\": \"Wendy Kohlmann\", \"authorId\": \"A5058251924\"}, {\"name\": \"Allison W. Kurian\", \"authorId\": \"A5067783851\"}, {\"name\": \"Jennifer K. Litton\", \"authorId\": \"A5014713051\"}, {\"name\": \"P. Kelly Marcom\", \"authorId\": \"A5005726073\"}, {\"name\": \"Robert L. Nussbaum\", \"authorId\": \"A5044887457\"}, {\"name\": \"Kenneth Offit\", \"authorId\": \"A5001757617\"}, {\"name\": \"Tuya Pal\", \"authorId\": \"A5036878328\"}, {\"name\": \"Boris Pasche\", \"authorId\": \"A5042254050\"}, {\"name\": \"Robert Pilarski\", \"authorId\": \"A5050505009\"}, {\"name\": \"Gwen Reiser\", \"authorId\": \"A5006175736\"}, {\"name\": \"Kristen M. Shannon\", \"authorId\": \"A5050037868\"}, {\"name\": \"Jeffrey R. Smith\", \"authorId\": \"A5075359536\"}, {\"name\": \"Elizabeth M. Swisher\", \"authorId\": \"A5084420374\"}, {\"name\": \"Jeffrey N. Weitzel\", \"authorId\": \"A5029960276\"}], \"link\": \"https://jnccn.org/downloadpdf/journals/jnccn/8/5/article-p562.pdf\", \"explanation\": \"The paper focuses on genetic/familial high-risk assessment for breast and ovarian cancer, particularly related to BRCA1 and BRCA2 mutations. It discusses cancer risks, genetic counseling, and management strategies for individuals with these mutations. However, it does not address cognitive abilities or intelligence in individuals with BRCA2 mutations, which is the focus of the claim. Therefore, the paper is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\\u2019s disease\", \"authors\": [{\"name\": \"Tiantian Guo\", \"authorId\": \"A5101888556\"}, {\"name\": \"Denghong Zhang\", \"authorId\": \"A5103274762\"}, {\"name\": \"Yuzhe Zeng\", \"authorId\": \"A5077259579\"}, {\"name\": \"Timothy Y. Huang\", \"authorId\": \"A5060805677\"}, {\"name\": \"Huaxi Xu\", \"authorId\": \"A5010227886\"}, {\"name\": \"Yingjun Zhao\", \"authorId\": \"A5071728727\"}], \"link\": \"https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-020-00391-7\", \"explanation\": \"The paper focuses on the molecular and cellular mechanisms underlying Alzheimer's disease, including discussions on amyloid-beta, tau proteins, and neuroinflammation. It does not address the cognitive abilities or intelligence of individuals with BRCA-2 mutations, nor does it compare their intelligence to the general population. Therefore, the content is not relevant to the claim about BRCA-2 mutations and intelligence.\"}, {\"title\": \"A systematic review of perceived risks, psychological and behavioral impacts of genetic testing\", \"authors\": [{\"name\": \"Jodi Heshka\", \"authorId\": \"A5062698422\"}, {\"name\": \"Crystal Palleschi\", \"authorId\": \"A5043780158\"}, {\"name\": \"Heather Howley\", \"authorId\": \"A5040198700\"}, {\"name\": \"Brenda J. Wilson\", \"authorId\": \"A5000740747\"}, {\"name\": \"Philip S. Wells\", \"authorId\": \"A5105782058\"}], \"link\": \"http://www.gimjournal.org/article/S1098360021028811/pdf\", \"explanation\": \"The paper focuses on the psychological, behavioral, and perceived risk impacts of genetic testing, specifically for hereditary diseases like breast and ovarian cancer, but does not address cognitive abilities or intelligence in individuals with a BRCA-2 mutation. There is no discussion or data related to intelligence or cognitive performance, which is the central aspect of the claim.\"}, {\"title\": \"Impact cognitif, \\u00e9motionnel et comportemental d\\u2019un r\\u00e9sultat BRCA1/2 incertain : revue de la litt\\u00e9rature\", \"authors\": [{\"name\": \"D\\u00e9bora Leblond\", \"authorId\": \"A5051168869\"}, {\"name\": \"Anne Br\\u00e9dart\", \"authorId\": \"A5003876955\"}, {\"name\": \"Sylvie Dolbeault\", \"authorId\": \"A5021567216\"}, {\"name\": \"Antoine De Pauw\", \"authorId\": \"A5046777066\"}, {\"name\": \"Dominique Stoppa Lyonnet\", \"authorId\": \"A5055702436\"}, {\"name\": \"C\\u00e9cile Flahault\", \"authorId\": \"A5007279813\"}, {\"name\": \"Serge Sultan\", \"authorId\": \"A5056194952\"}], \"link\": \"https://doi.org/10.1684/bdc.2011.1309\", \"explanation\": \"The paper focuses on the psychological impact of uncertain BRCA1/2 genetic test results on emotional, cognitive, and behavioral reactions. It does not address cognitive abilities or intelligence levels of individuals with BRCA-2 mutations, which is the focus of the claim.\"}, {\"title\": \"Emerging tobacco hazards in China\", \"authors\": [{\"name\": \"TH Lam\", \"authorId\": \"A5060005501\"}, {\"name\": \"Sai Yin Ho\", \"authorId\": \"A5056331600\"}, {\"name\": \"Y Lhatoo\", \"authorId\": \"A5028068639\"}, {\"name\": \"Richard Peto\", \"authorId\": \"A5041941850\"}, {\"name\": \"Z.-M. Chen\", \"authorId\": \"A5036330396\"}, {\"name\": \"J Boreham\", \"authorId\": \"A5113667415\"}], \"link\": \"https://europepmc.org/articles/pmc1115915?pdf=render\", \"explanation\": \"The paper content provided does not discuss the BRCA-2 mutation or its effects on intelligence or cognitive abilities. The content primarily focuses on topics related to organ donation, myocardial infarction treatment, tobacco hazards, and other unrelated medical issues. Therefore, it is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"Family Communication about Genetic Risk: The Little That Is Known\", \"authors\": [{\"name\": \"Brenda J. Wilson\", \"authorId\": \"A5000740747\"}, {\"name\": \"Karen Forrest\", \"authorId\": \"A5010452557\"}, {\"name\": \"Edwin van Teijlingen\", \"authorId\": \"A5076631479\"}, {\"name\": \"Martin McKee\", \"authorId\": \"A5027320968\"}, {\"name\": \"Neva E. Haites\", \"authorId\": \"A5110845849\"}, {\"name\": \"Eric Matthews\", \"authorId\": \"A5103448864\"}, {\"name\": \"Sheila A Simpson\", \"authorId\": \"A5103543581\"}], \"link\": \"https://doi.org/10.1159/000080300\", \"explanation\": \"The paper focuses on family communication in clinical genetics and the sharing of genetic risk information among family members. It does not address cognitive abilities or intelligence in individuals with a BRCA-2 mutation, nor does it compare their intelligence to the general population.\"}, {\"title\": \"The impact of site-specific digital histology signatures on deep learning model accuracy and bias\", \"authors\": [{\"name\": \"Frederick M. Howard\", \"authorId\": \"A5031652616\"}, {\"name\": \"James M. Dolezal\", \"authorId\": \"A5031584100\"}, {\"name\": \"Sara Kochanny\", \"authorId\": \"A5048899616\"}, {\"name\": \"Jefree J. Schulte\", \"authorId\": \"A5057611921\"}, {\"name\": \"Heather Chen\", \"authorId\": \"A5058364311\"}, {\"name\": \"Lara R. Heij\", \"authorId\": \"A5008499568\"}, {\"name\": \"Dezheng Huo\", \"authorId\": \"A5015502083\"}, {\"name\": \"Rita Nanda\", \"authorId\": \"A5005007467\"}, {\"name\": \"Olufunmilayo I. Olopade\", \"authorId\": \"A5057209864\"}, {\"name\": \"Jakob Nikolas Kather\", \"authorId\": \"A5073483894\"}, {\"name\": \"Nicole A. Cipriani\", \"authorId\": \"A5003234579\"}, {\"name\": \"Robert L. Grossman\", \"authorId\": \"A5050853661\"}, {\"name\": \"Alexander T. Pearson\", \"authorId\": \"A5031626209\"}], \"link\": \"https://www.nature.com/articles/s41467-021-24698-1.pdf\", \"explanation\": \"The paper focuses on the impact of site-specific digital histology signatures on deep learning model accuracy and bias in cancer research. It does not address cognitive abilities or intelligence in individuals with BRCA-2 mutations, nor does it compare their intelligence to the general population. Therefore, it is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"Genetic Polymorphisms in Sepsis and Septic Shock\", \"authors\": [{\"name\": \"Cheryl L. Holmes\", \"authorId\": \"A5070741496\"}, {\"name\": \"James A. Russell\", \"authorId\": \"A5107929230\"}, {\"name\": \"Keith R. Walley\", \"authorId\": \"A5010687095\"}], \"link\": \"https://doi.org/10.1378/chest.124.3.1103\", \"explanation\": \"The paper focuses on genetic influences on sepsis and the inflammatory response, discussing various genes related to these conditions. It does not address the BRCA-2 mutation or any cognitive or intelligence-related outcomes, making it irrelevant to the claim about BRCA-2 mutation and intelligence.\"}, {\"title\": \"Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations\", \"authors\": [{\"name\": \"George Uchenna Eleje\", \"authorId\": \"A5083668009\"}, {\"name\": \"Ahizechukwu C. Eke\", \"authorId\": \"A5038922938\"}, {\"name\": \"Ifeanyichukwu U. Ezebialu\", \"authorId\": \"A5016322825\"}, {\"name\": \"Joseph Ifeanyichukwu Ikechebelu\", \"authorId\": \"A5000012369\"}, {\"name\": \"Emmanuel Onyebuchi Ugwu\", \"authorId\": \"A5081769927\"}, {\"name\": \"Onyinye O Okonkwo\", \"authorId\": \"A5057586579\"}], \"link\": \"https://europepmc.org/articles/pmc6513554?pdf=render\", \"explanation\": \"The paper is not relevant to the claim as it does not address or provide any information regarding the intelligence or cognitive abilities of individuals with BRCA2 mutations. The focus is entirely on cancer risk and the effects of surgical interventions.\"}, {\"title\": \"Ethical Standards for Human-to-Animal Chimera Experiments in Stem Cell Research\", \"authors\": [{\"name\": \"Insoo Hyun\", \"authorId\": \"A5044020659\"}, {\"name\": \"Patrick Taylor\", \"authorId\": \"A5087207299\"}, {\"name\": \"Giuseppe Testa\", \"authorId\": \"A5087706646\"}, {\"name\": \"Bernard M. Dickens\", \"authorId\": \"A5089962510\"}, {\"name\": \"Kyu Won Jung\", \"authorId\": \"A5000382245\"}, {\"name\": \"Angela McNab\", \"authorId\": \"A5055185235\"}, {\"name\": \"John A. Robertson\", \"authorId\": \"A5110425590\"}, {\"name\": \"Loane Skene\", \"authorId\": \"A5112150863\"}, {\"name\": \"Laurie Zoloth\", \"authorId\": \"A5041830749\"}], \"link\": \"http://www.cell.com/article/S193459090700080X/pdf\", \"explanation\": \"The paper focuses on ethical standards for research involving human-to-animal chimeras and stem cell research. It does not address the cognitive abilities or intelligence of individuals with a BRCA-2 mutation, nor does it discuss any genetic or cognitive comparisons between people with BRCA-2 mutations and the general population.\"}, {\"title\": \"A vision for the future of genomics research\", \"authors\": [{\"name\": \"Francis S. Collins\", \"authorId\": \"A5068242165\"}, {\"name\": \"Eric D. Green\", \"authorId\": \"A5107244756\"}, {\"name\": \"Alan E. Guttmacher\", \"authorId\": \"A5111622584\"}, {\"name\": \"Mark S. Guyer\", \"authorId\": \"A5000299667\"}], \"link\": \"https://www.nature.com/articles/nature01626.pdf\", \"explanation\": \"The paper is focused on the future of genomics research, the Human Genome Project, and the implications of genomics in various fields such as health, society, and technology. It does not discuss the BRCA-2 mutation or any cognitive or intelligence-related traits associated with genetic mutations. Therefore, it does not provide any information relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"On the incomplete architecture of human ontogeny: Selection, optimization, and compensation as foundation of developmental theory.\", \"authors\": [{\"name\": \"Paul B. Baltes\", \"authorId\": \"A5077002731\"}], \"link\": \"https://pure.mpg.de/pubman/item/item_2103220_9/component/file_2103219/PB_On_1997.pdf\", \"explanation\": \"The paper discusses the architecture of human development from a lifespan perspective, focusing on concepts like selection, optimization, and compensation, as well as the biological and cultural factors influencing development. It does not address the BRCA-2 mutation or any genetic factors related to intelligence or cognitive abilities. Therefore, it is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"Disparities in BRCA testing: when insurance coverage is not a barrier\", \"authors\": [{\"name\": \"Windy Olaya\", \"authorId\": \"A5031214005\"}, {\"name\": \"Pamela Esquivel\", \"authorId\": \"A5063335978\"}, {\"name\": \"Jan H. Wong\", \"authorId\": \"A5103162694\"}, {\"name\": \"John W. Morgan\", \"authorId\": \"A5107483217\"}, {\"name\": \"Adam Freeberg\", \"authorId\": \"A5002842387\"}, {\"name\": \"Sharmila Roy-Chowdhury\", \"authorId\": \"A5073656706\"}, {\"name\": \"Sharon S. Lum\", \"authorId\": \"A5073933506\"}], \"link\": \"https://doi.org/10.1016/j.amjsurg.2009.07.003\", \"explanation\": \"The paper focuses on the factors influencing the decision to undergo BRCA genetic testing and does not address any cognitive or intelligence-related outcomes associated with BRCA-2 mutations. There is no discussion or data presented in the paper that relates to the intelligence or cognitive abilities of individuals with BRCA-2 mutations.\"}, {\"title\": \"Influence of Race/Ethnicity on Genetic Counseling and Testing for Hereditary Breast and Ovarian Cancer\", \"authors\": [{\"name\": \"Andrea Forman\", \"authorId\": \"A5003759103\"}, {\"name\": \"Michael J. Hall\", \"authorId\": \"A5009072858\"}], \"link\": \"https://doi.org/10.1111/j.1524-4741.2009.00798.x\", \"explanation\": \"The paper focuses on the influence of race/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer, specifically related to BRCA1 and BRCA2 mutations. It does not address cognitive abilities or intelligence in individuals with BRCA-2 mutations, nor does it compare their intelligence to the general population.\"}, {\"title\": \"Decision making for breast cancer prevention among women at elevated risk\", \"authors\": [{\"name\": \"Tasleem J. Padamsee\", \"authorId\": \"A5025976520\"}, {\"name\": \"Celia E. Wills\", \"authorId\": \"A5056484220\"}, {\"name\": \"Lisa D. Yee\", \"authorId\": \"A5030823966\"}, {\"name\": \"Electra D. Paskett\", \"authorId\": \"A5029182022\"}], \"link\": \"https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/s13058-017-0826-5\", \"explanation\": \"The paper focuses on decision-making processes for breast cancer prevention among women with BRCA mutations, including BRCA-2. It discusses genetic testing, risk management, and prevention strategies but does not address cognitive abilities or intelligence levels of individuals with BRCA-2 mutations. Therefore, it does not provide any information relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"Using fuzzy-trace theory to understand and improve health judgments, decisions, and behaviors: A literature review.\", \"authors\": [{\"name\": \"Susan J. Blalock\", \"authorId\": \"A5045885628\"}, {\"name\": \"Valerie F. Reyna\", \"authorId\": \"A5004562983\"}], \"link\": \"https://doi.org/10.1037/hea0000384\", \"explanation\": \"The paper focuses on fuzzy-trace theory and its application to health-related judgments, decisions, and behaviors. It does not address genetic mutations such as BRCA-2 or their impact on intelligence or cognitive abilities. Therefore, it is not relevant to the claim that people with a BRCA-2 mutation are smarter than the general population.\"}, {\"title\": \"Low-Dose Heparin for Severe Sepsis\", \"authors\": [{\"name\": \"Bruce L. Davidson\", \"authorId\": \"A5108087183\"}, {\"name\": \"William Geerts\", \"authorId\": \"A5052169179\"}, {\"name\": \"Anthonie W.A. Lensing\", \"authorId\": \"A5110204919\"}], \"link\": \"https://www.nejm.org/doi/pdf/10.1056/NEJM200209263471316?articleTools=true\", \"explanation\": \"The paper content provided is about the efficacy of activated protein C in reducing mortality from sepsis, which is unrelated to the claim about BRCA-2 mutation and intelligence. There is no mention of BRCA-2 mutations, intelligence, or any related cognitive assessments in the provided content.\"}], \"explanation\": \"No relevant papers were found for this claim after analysis.\", \"claimRating\": 0}"
}